Skip to main content
peptidesinburleson

Peptides studied for tissue repair, tendon/ligament healing, gut mucosa, wound healing and angiogenesis.

RECOVERY & TISSUE REPAIR / COLOPHON

About This Almanac

A citation-anchored almanac of the recovery-peptide literature — the Wolverine blend, BPC-157, and TB-500. Nothing sold, no one treated, no advice given.

What this almanac gathers

peptidesinburleson is an almanac of three entries in the tissue-repair peptide space: the Wolverine blend (BPC-157 + TB-500) as the lead concept, and its two constituent research peptides — BPC-157 and TB-500 — on their own compound pages. Its job is to make a scattered, frequently overstated, and technically demanding literature legible — to set down, in precise language and with citations, what each compound was actually studied for, in which species, and how far that evidence reaches.

The blend itself is the organizing entry: two peptides paired on the theory that their mechanisms complement each other — a scientifically interesting idea that, as of the current literature, no controlled study has confirmed. Working out what BPC-157 and TB-500 each actually do in animals, and where their evidence thins, is the precondition for weighing the blend honestly. Each compound gets its own page, a comparison page sets them side by side, and one shared reference list gathers every source.

How the almanac is kept

The almanac draws only on peer-reviewed sources: PubMed-indexed journal articles, systematic reviews, narrative reviews, clinical trial records, and formal pharmacokinetic studies. Every claim on a compound page links to a numbered reference giving authors, journal, year, PubMed ID, and DOI where available. One references list compiles the full set across all pages.

Where the evidence is preclinical (animal or cell-culture), the page says so. Where it comes from a single research group, the replication limits are noted. Where community-reported effects appear — anecdotal accounts from research-use communities — they wear an explicit anecdotal, not clinical evidence label and sit apart from the literature findings. Anecdote is never passed off as study data, and study data is never passed off as though it maps straight onto human experience.

No human dose is stated anywhere in the almanac. No regimen is recommended. No product is promoted or sold. The site makes no medical claims and is not medical advice.

What the almanac is not

peptidesinburleson is tied to no peptide supplier, compounding pharmacy, or commercial entity. It sells nothing. It names and links to no supplier. It hands out no clinical recommendations. There is no author bio, no practitioner claim, no office address, and no appointment booking — because none of that exists here. "Burleson" in the name is a brand tag, not a location; this is a reading of the literature, not a local service.

Anyone seeking medical advice should consult a licensed healthcare provider who can weigh their specific situation. The almanac makes no claim to stand in for that relationship, and its summaries should be read as maps of the published science, not as treatment guides.